Literature DB >> 12562698

Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals.

G S Simonsen1, L Småbrekke, D L Monnet, T L Sørensen, J K Møller, K G Kristinsson, A Lagerqvist-Widh, E Torell, A Digranes, S Harthug, A Sundsfjord.   

Abstract

We determined the species distribution and prevalence of ampicillin resistance, high-level gentamicin resistance (HLGR) and vancomycin resistance among clinical enterococcal isolates from five Nordic laboratories (Bergen, Tromsø, Uppsala, Aarhus and Reykjavik). Isolates represented three different groups: (i) all blood culture isolates from 1999; (ii) consecutive in-patient isolates (maximum 40); and (iii) consecutive outpatient isolates (maximum 40) collected during March to May 2000. Antimicrobial use data were collected at the national and hospital level. A high proportion (31.4%) of Enterococcus faecium was detected among blood culture isolates, in contrast to only 4.2% among isolates from outpatients. Ampicillin resistance was not found in Enterococcus faecalis, in contrast to 48.8% in E. faecium isolates. HLGR rates varied considerably between laboratories (1.1-27.6%). Acquired vancomycin resistance was not detected. There were no significant differences in the prevalences of HLGR between in-patient and outpatient isolates at individual hospitals. A cluster of clonally related ampicillin-resistant and HLGR E. faecium isolates was demonstrated in one of the hospitals. The lowest level of hospital antimicrobial use, the lowest proportion of E. faecium and the lowest prevalence of resistance were observed in Reykjavik. The study showed a relatively low level of resistance in enterococci, as compared with most European countries and the USA. However, there were large differences between hospitals with regard to the relative proportion of E. faecium isolates, their susceptibility to ampicillin and gentamicin, as well as the prevalence of HLGR in E. faecalis isolates. This indicates a potential for further improvement of antibiotic policies, and possibly hospital infection control, to maintain the low resistance levels observed in these countries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12562698     DOI: 10.1093/jac/dkg052

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

1.  Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions.

Authors:  Inger Kühn; Aina Iversen; Maria Finn; Christina Greko; Lars G Burman; Anicet R Blanch; Xavier Vilanova; Albert Manero; Huw Taylor; Jonathan Caplin; Lucas Domínguez; Inmaculada A Herrero; Miguel A Moreno; Roland Möllby
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

2.  Molecular epidemiology of enterococcal bacteremia in Australia.

Authors:  Geoffrey W Coombs; Julie C Pearson; Denise A Daley; Tam Le; Owen J Robinson; Thomas Gottlieb; Benjamin P Howden; Paul D R Johnson; Catherine M Bennett; Timothy P Stinear; John D Turnidge
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

3.  A 7-year study of bloodstream infections in an English children's hospital.

Authors:  James W Gray
Journal:  Eur J Pediatr       Date:  2004-07-06       Impact factor: 3.183

4.  Multiple-locus variable-number tandem repeat analysis, a novel typing scheme to study the genetic relatedness and epidemiology of Enterococcus faecium isolates.

Authors:  Janetta Top; Leo M Schouls; Marc J M Bonten; Rob J L Willems
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

5.  Emergence of clonal complex 17 Enterococcus faecium in The Netherlands.

Authors:  Janetta Top; Rob Willems; Saskia van der Velden; Miranda Asbroek; Marc Bonten
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

6.  Bloodstream isolates of Enterococcus faecium enriched with the enterococcal surface protein gene, esp, show increased adhesion to eukaryotic cells.

Authors:  Bodil Lund; Charlotta Edlund
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

7.  High level aminoglycoside resistant enterococci in hospital-acquired urinary tract infections in Mansoura, Egypt.

Authors:  Rasha El-Mahdy; Ahmed Mostafa; Ghada El-Kannishy
Journal:  Germs       Date:  2018-12-03

8.  Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex.

Authors:  Rob J L Willems; Janetta Top; Marga van Santen; D Ashley Robinson; Teresa M Coque; Fernando Baquero; Hajo Grundmann; Marc J M Bonten
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

9.  Vancomycin-resistant enterococci in a Chinese hospital.

Authors:  S Li; Z Zhang; Z H Mi
Journal:  Curr Microbiol       Date:  2007-07-04       Impact factor: 2.343

10.  In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin-Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis with High Levels of Aminoglycoside Resistance.

Authors:  Maria Bruna Pasticci; Antonella Mencacci; Amedeo Moretti; Nicola Palladino; Luigi Maria Lapalorcia; Francesco Bistoni; Franco Baldelli
Journal:  Open Microbiol J       Date:  2008-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.